First-line treatment for primary testicular diffuse large B-cell lymphoma with rituximab-CHOP, CNS prophylaxis, and contralateral testis irradiation: final results of an international phase II trial

Clicks: 583
ID: 113389
2011
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #2 of 24 articles by views in journal of clinical oncology : official journal of the american society of clinical oncology

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
This international prospective trial shows that combined treatment with R-CHOP21, IT-MTX, and testicular RT was associated with a good outcome in patients with PTL. RT avoided contralateral testis relapses, but CNS prophylaxis deserves further investigation.
Reference Key
u2011journalfirst-line Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Vitolo U;Chiappella A;Ferreri AJ;Martelli M;Baldi I;Balzarotti M;Bottelli C;Conconi A;Gomez H;Lopez-Guillermo A;Martinelli G;Merli F;Novero D;Orsucci L;Pavone V;Ricardi U;Storti S;Gospodarowicz MK;Cavalli F;Sarris AH;Zucca E;;
Journal journal of clinical oncology : official journal of the american society of clinical oncology
Year 2011
DOI
DOI not found
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.